Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison
Recruiting
Observational Study
Brain Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Region Stockholm · Government
Who this trial is looking for
This trial is looking for people who are 18 or older and are scheduled for a brain MRI with contrast. Participants will receive a standard MRI and a new type of MRI to see if it can find more brain tumors.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 years old or older.
I am scheduled for a brain MRI with gadolinium contrast.
I have known or suspected brain metastases.
I can provide informed consent.
I can lie still during the MRI.
You may not be able to join if
I have contraindications to MRI.
I have a known allergy to gadolinium-based contrast agents.
I have renal impairment.
I am pregnant or breastfeeding.
I cannot comply with the study procedures.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This study will evaluate a new type of MRI sequence designed to improve the visibility of brain metastases after gadolinium contrast injection. The purpose is to determine whether this novel "gadolinium-weighted" imaging method can detect more or smaller tumors than standard MRI techniques. Participants will undergo a routine brain MRI with contrast, followed by an additional scan using the new me…
This study will evaluate a new type of MRI sequence designed to improve the visibility of brain metastases after gadolinium contrast injection. The purpose is to determine whether this novel "gadolinium-weighted" imaging method can detect more or smaller tumors than standard MRI techniques. Participants will undergo a routine brain MRI with contrast, followed by an additional scan using the new method. The goal is to improve diagnostic accuracy without increasing the contrast dose or scan time.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or older
* Scheduled for clinical brain MRI with gadolinium contrast
* Known or suspected brain metastases
* Able to provide informed consent
* Able to lie still for the duration of the MRI examination
Exclusion Criteria:
* Contraindications to MRI
* Known aller…
Inclusion Criteria:
* Age 18 years or older
* Scheduled for clinical brain MRI with gadolinium contrast
* Known or suspected brain metastases
* Able to provide informed consent
* Able to lie still for the duration of the MRI examination
Exclusion Criteria:
* Contraindications to MRI
* Known allergy or contraindication to gadolinium-based contrast agents
* Renal impairment (eGFR \< 30 mL/min/1.73m²)
* Pregnant or breastfeeding
* Inability to comply with study procedures
Contacts
No contact information available.
What are you hoping to find?
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.